Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Argiris, Athanassios
Item TypeName
Concept Antibodies, Monoclonal
Concept Antibodies, Monoclonal, Humanized
Academic Article Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer.
Academic Article Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patients.
Academic Article Emerging molecular targeted therapies in squamous cell carcinoma of the head and neck.
Academic Article Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer.
Academic Article Phase II trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancer.
Academic Article Therapies directed against epidermal growth factor receptor in aerodigestive carcinomas.
Academic Article Phase II study of cetuximab in combination with cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern cooperative oncology group trial E3303.
Academic Article Targeting GPCR-mediated p70S6K activity may improve head and neck cancer response to cetuximab.
Academic Article Phase I and pharmacokinetic study of dasatinib and cetuximab in patients with advanced solid malignancies.
Academic Article Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancer.
Academic Article Synergistic interactions between tamoxifen and trastuzumab (Herceptin).
Academic Article CTLA-4? Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis.
Academic Article Tumor epidermal growth factor receptor and EGFR PY1068 are independent prognostic indicators for head and neck squamous cell carcinoma.
Academic Article Growth and molecular interactions between tamoxifen and trastuzumab.
Academic Article Characterization of human papillomavirus antibodies in individuals with head and neck cancer.
Academic Article Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer.
Search Criteria
  • Antibodies